Journal of the science of food and agriculture
Cure8 research brief
Why This Matters
The study suggests a fermented seaweed-derived fiber reduced inflammation and oxidative stress in cells and a mouse colitis model and modified gut microbiota and short-chain fatty acids, which could guide future dietary or microbiome-focused IBD research.
Who Should Pay Attention
Researchers (microbiome, preclinical therapeutics), clinicians following experimental dietary interventions, and patients curious about diet-based strategies (note: preclinical evidence only).
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The work is preclinical: results come from cell experiments and a dextran sulfate sodium (DSS) mouse model of colitis, not from human trials. The study measured reductions in inflammatory cytokines and increases in antioxidant enzyme activity and identified shifts in bacterial taxa and short-chain fatty acids after BL-SDF treatment.
Because this is an abstract-level summary from the journal, it shows a potential preventive effect in animals but does not establish safety or efficacy in people with IBD. It may point toward future dietary or microbiome-targeted research, not clinical recommendations.
Keep In Mind
Results are from cell assays and a DSS-induced mouse model; human safety and efficacy are not established. The article is an academic preclinical study, not a clinical trial.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationJournal of the science of food and agriculture
AuthorsHongying Cai, Enlin Li, Zhuo Wang +9 more
InstitutionShenzhen Research Institute, Guangdong Ocean University, Shenzhen, China.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedOct 14, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Lactiplantibacillus plantarum BF_15 Confers Protection Against Ulcerative Colitis by Orchestrating Gut Microbiota-Barrier-Immune Triad Homeostasis.
Early-stage research suggests a specific probiotic strain may reduce inflammation and alter the gut microbiome and immune-related proteins in an animal model of ulcerative colitis, which could point to future therapeutic...
Marine Collagen Peptide Fraction from Lutjanus erythropterus Scales: A Multifunctional Bioactive for Intestinal Barrier Protection and Redox Modulation in Ulcerative Colitis
This preclinical study suggests a marine-derived collagen peptide fraction may strengthen intestinal barrier function, reduce oxidative stress, and partially restore gut microbiota in models of colitis — mechanisms...
Erythritol Exacerbates DSS-Induced Colitis and Influences Behavioral Responses in Mice Through Gut Microbiota and Metabolic Alterations
This study suggests erythritol — a common non-nutritive sweetener — may worsen experimental colitis and depression-like behavior in mice via microbiome and metabolic changes, raising questions about how ultra-processed...